Zika Virus Information for Researchers

A photo of a vial of the NIAID Zika Virus Investigational DNA Vaccine

A vial of the NIAID Zika Virus Investigational DNA Vaccine, taken at the NIAID Vaccine Research Center’s Pilot Plant in Frederick, Maryland.

Credit
NIAID

A vial of the NIAID Zika Virus Investigational DNA Vaccine, taken at the NIAID Vaccine Research Center’s Pilot Plant in Frederick, Maryland.

Credit: NIAID

NIAID is conducting and supporting research to find new and improved ways to diagnose, treat, and prevent Zika virus infections. Through the information offered here, the scientific community can learn about NIAID funding opportunities, programs, and networks to further research and encourage collaboration. This section also provides information on resources provided by NIAID to advance product development.    

Funding Opportunities

NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential or related funding for Zika virus research.

Program Officers 

For contact information, search the NIH Enterprise Directory.

  • Dr. Mark Challberg, Chief, Virology Branch
  • Dr. Mindy Davis, Program Officer, Antiviral Research, Virology Branch
  • Dr. Walla Dempsey, Program Officer, Clinical Research, Virology Branch
  • Dr. Kaitlyn Morabito, Program Officer, Flaviviruses, Virology Branch
  • Dr. Michael Schaefer, Chief, Translational Centers of Excellence and Research Coordination Section, Office of Biodefense Research Resources and Translational Research
  • Dr. Sara Woodson, Team Lead, Centers for Research in Emerging Infectious Diseases (CREID) Network

 

Resources for Researchers

NIAID offers resources to advance science from basic research through advanced clinical evaluation, with the goal of developing new and improved products such as diagnostics, vaccines and therapeutics. Resources to support basic research include the BEI Resources Repository, which provides organisms and reagents to the scientific community, while clinical research resources include the Vaccine and Treatment Evaluation Units., which conduct Phase I, II, and IV clinical trials across the United States.

Available preclinical services programs include:


See a full list of resources for Zika researchers

Programs & Networks

The NIAID-funded Centers of Excellence for Translational Research program is funding innovative research to develop novel therapeutics and vaccines against Zika virus.

NIAID also funds the Centers for Research in Emerging Infectious Diseases (CREID), a global network of multidisciplinary investigations into how and where viruses and other pathogens can emerge from wildlife and spillover to cause disease in people. Research is led by 10 Centers and one Coordinating Center and involves collaborations with peer institutions in the United States and 28 other countries.


Read more about Zika research networks funded by NIAID

Connect With Other Researchers

Content last reviewed on